Literature DB >> 11240582

Naltrexone as a treatment of self-injurious behavior--a case report.

H Griengl1, A Sendera, K Dantendorfer.   

Abstract

OBJECTIVE: Self-injurious (SIB) is a phenomenon associated with different psychopathological conditions such as psychosis, mental retardation and especially severe personality disorders--mainly of the borderline subtype. It has been suggested that a blockade of the endogenous opoid system might lead to a reduction of the urge to SIB.
METHOD: The case and successful treatment of SIB with naltrexone in a patient with borderline personality disorder and dysthymia is described.
RESULTS: After treatment trials with neuroleptics, antidepressants and valproate the patient was treated with naltrexone in a dosis of 50 mg/day and did not show SIB over a follow-up period of 32 weeks.
CONCLUSION: Naltrexone could be effective in reducing SIB in patients with psychiatric disorders by blocking the positive reinforcement of SIB, which is released by the release of endogenous opoides. Placebo-controlled studies of the efficacy of naltrexone in treating SIB should be undertaken.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11240582     DOI: 10.1034/j.1600-0447.2001.00087.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  3 in total

Review 1.  Medications in the treatment of borderline personality disorder 2006.

Authors:  Deanna Mercer
Journal:  Curr Psychiatry Rep       Date:  2007-02       Impact factor: 8.081

2.  The Potential Role of Naltrexone in Borderline Personality Disorder.

Authors:  Azadeh Moghaddas; Mehrnoush Dianatkhah; Saba Ghaffari; Padideh Ghaeli
Journal:  Iran J Psychiatry       Date:  2017-04

3.  Deliberate Foreign Body Ingestion in a 35-Year-Old Woman With Borderline Personality Disorder and Several Psychiatric Comorbidities.

Authors:  Fariha Bangash; James L Megna; Luba Leontieva
Journal:  Cureus       Date:  2021-02-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.